Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (271-280 of 752) with videos related to

Pageof 76
Sort By:
Journal of Thrombosis and Thrombolysis|August 6, 2005
The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarctionMarc Cohen, Gian Franco Gensini, Frans Maritz, et al.
JACC. Cardiovascular Interventions|July 23, 2011
Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trialBernhard Witzenbichler, Roxana Mehran, Giulio Guagliumi, et al.
Coronary Artery Disease|November 14, 2008
Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteriesRayyan Hemetsberger, Serdar Farhan, Christoph Strehblow, et al.
Stroke|December 26, 2013
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysisGhazaleh Gouya, Jasmin Arrich, Michael Wolzt, et al.
The American Journal of Cardiology|March 27, 2013
Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarctionZafar Iqbal, Marc Cohen, Charles Pollack, et al.
Thrombosis and Haemostasis|December 29, 2018
Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary InterventionMaximilian Tscharre, Birgit Vogel, Ioannis Tentzeris, et al.
Thrombosis and Haemostasis|February 24, 2017
Platelet turnover predicts outcome after coronary interventionMatthias K Freynhofer, Liana Iliev, Veronika Bruno, et al.
Lancet (London, England)|May 29, 2007
A mimic of sarcoidosisLarisa Dzirlo, Marianne Hubner, Christian Müller, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2016
Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarctionBarbara Fellner, Miklos Rohla, Rudolf Jarai, et al.
Circulation. Cardiovascular Quality and Outcomes|June 3, 2021
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation RegistriesMiklos Rohla, Ladislav Pecen, Roberto Cemin, et al.
Pageof 76

Showing results (271-280 of 752) with videos related to

Sort By:
Pageof 76
Journal of Thrombosis and Thrombolysis|August 6, 2005
The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarctionMarc Cohen, Gian Franco Gensini, Frans Maritz, et al.
JACC. Cardiovascular Interventions|July 23, 2011
Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trialBernhard Witzenbichler, Roxana Mehran, Giulio Guagliumi, et al.
Coronary Artery Disease|November 14, 2008
Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteriesRayyan Hemetsberger, Serdar Farhan, Christoph Strehblow, et al.
Stroke|December 26, 2013
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysisGhazaleh Gouya, Jasmin Arrich, Michael Wolzt, et al.
The American Journal of Cardiology|March 27, 2013
Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarctionZafar Iqbal, Marc Cohen, Charles Pollack, et al.
Thrombosis and Haemostasis|December 29, 2018
Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary InterventionMaximilian Tscharre, Birgit Vogel, Ioannis Tentzeris, et al.
Thrombosis and Haemostasis|February 24, 2017
Platelet turnover predicts outcome after coronary interventionMatthias K Freynhofer, Liana Iliev, Veronika Bruno, et al.
Lancet (London, England)|May 29, 2007
A mimic of sarcoidosisLarisa Dzirlo, Marianne Hubner, Christian Müller, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2016
Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarctionBarbara Fellner, Miklos Rohla, Rudolf Jarai, et al.
Circulation. Cardiovascular Quality and Outcomes|June 3, 2021
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation RegistriesMiklos Rohla, Ladislav Pecen, Roberto Cemin, et al.
Pageof 76